Aerovate Therapeutics, Inc.

NASDAQ (USD): Aerovate Therapeutics, Inc. (AVTE)

Last Price

2.06

Today's Change

-0.02 (0.96%)

Day's Change

2.05 - 2.11

Trading Volume

133,086

Overview

Market Cap

59 Million

Shares Outstanding

28 Million

Avg Volume

404,585

Avg Price (50 Days)

1.85

Avg Price (200 Days)

14.59

PE Ratio

-0.66

EPS

-3.13

Earnings Announcement

11-Nov-2024

Previous Close

2.08

Open

2.07

Day's Range

2.05 - 2.11

Year Range

1.25 - 32.415

Trading Volume

133,086

Price Change Highlight

1 Day Change

-0.96%

5 Day Change

7.29%

1 Month Change

10.75%

3 Month Change

24.10%

6 Month Change

-93.03%

Ytd Change

-90.55%

1 Year Change

-84.97%

3 Year Change

-90.15%

5 Year Change

-90.98%

10 Year Change

-90.98%

Max Change

-90.98%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment